This Promising GLP-1 Drug Could Renew Novo Nordisk Hope
Novo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
Understanding the financial goals you should have at 55 is vital for retirement planning. Explore key objectives to focus on for success.
27,702 articlesNovo Nordisk has faced headwinds, but a new GLP-1 drug could change the game. This article breaks down what investors...
Investor nerves rose as here's gemini space station faced a sharp price drop this week. This piece breaks down what s...
An AI-led forecast suggests ripple (xrp) price prediction could push XRP to $500 by 2035, renewing debates about the ...
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
A major Ethereum Layer-2 network, Taiko, halted block production after an exploit. Blockaid suggests the root cause l...
A bold AI forecast points Bitcoin toward a multi-hundred thousand target by late 2026, if regulatory and market catal...
SpaceX stunned markets with a massive IPO haul and a rapid follow-up bond issue. This article breaks down what happen...
Cognition CEO Scott Wu says token-based leadership metrics have inflated AI spending. The firm urges measuring employ...
NuScale Power stock surged to a record before succumbing to a mix of policy, funding, and project risks. This guide b...
A sharp drop in Oddity Tech shares sparked questions about the health of a high-growth tech play. Even with solid qua...
As cyber threats rise, sentinelOne's 2026 earnings call will reveal how the company plans to expand its AI-driven pla...
Meta Platforms is pursuing a bold path toward a $9 trillion market cap by 2031. This article breaks down the feasibil...